Cytomegalovirus Post-Prophylaxis Surveillance in High-Risk Kidney and Liver Recipients Prevents CMV End-Organ Disease and Ganciclovir-Resistance.
Margaret R JorgensonEthan MeyerGlen E LeversonJillian L DescourouezChristopher M SaddlerJeannina A SmithJohn P RiceDidier A MandelbrotJon S OdoricoPublished in: Clinical transplantation (2024)
Post-prophylaxis surveillance significantly reduced CMV end-organ disease and resistance. Despite observing increased replication rates in the surveillance era, rejection was not significantly different and there was no graft loss or patient mortality at 12 months.